• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Control of Extensively Drug-Resistant Tuberculosis (XDR-TB): A Root Cause Analysis.广泛耐药结核病(XDR-TB)的控制:根本原因分析
Glob Health Gov. 2010 Spring;3(2):1-20. Epub 2010 Apr 1.
2
Tuberculosis结核病
3
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.抗击广泛耐药结核病计划:联邦结核病特别工作组的建议
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
4
The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada.广泛耐药结核病(TB)的出现:全球和加拿大的结核/艾滋病毒双重感染、耐多药结核病以及由此产生的广泛耐药结核病对公共卫生的威胁。
Can J Infect Dis Med Microbiol. 2007 Sep;18(5):289-91. doi: 10.1155/2007/986794.
5
Global burden of HIV-negative multidrug- and extensively drug-resistant tuberculosis based on Global Burden of Disease Study 2021.基于《2021年全球疾病负担研究》的HIV阴性多重耐药和广泛耐药结核病的全球负担
Sci One Health. 2024 Jul 4;3:100072. doi: 10.1016/j.soh.2024.100072. eCollection 2024.
6
Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.耐多药和广泛耐药结核病(M/XDR-TB):问题与解决方案
Indian J Tuberc. 2010 Oct;57(4):180-91.
7
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.四十年间广泛耐药结核病的演变:来自夸祖鲁 - 纳塔尔省结核分枝杆菌分离株的全基因组测序与年代分析
PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.
8
Representations of MDR and XDR-TB in South African newspapers.南非报纸上耐多药结核病和广泛耐药结核病的报道。
Soc Sci Med. 2012 Jul;75(2):410-8. doi: 10.1016/j.socscimed.2012.02.039. Epub 2012 Mar 30.
9
Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies.耐多药和广泛耐药结核病的管理:证据与争议
Lung India. 2012 Apr;29(2):154-9. doi: 10.4103/0970-2113.95321.
10
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.欧洲耐多药/广泛耐药结核病患者的管理:一份欧洲结核病研究和培训网络(TBNET)共识声明
Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

引用本文的文献

1
'We thought supporting was strengthening': re-examining the role of external assistance for health systems strengthening in Zimbabwe post-COVID-19.“我们原以为支持就是强化”:重新审视新冠疫情后外部援助在津巴布韦卫生系统强化中的作用
Health Policy Plan. 2024 Aug 8;39(7):652-660. doi: 10.1093/heapol/czae052.
2
Whole-genome sequencing in outbreak analysis.暴发分析中的全基因组测序
Clin Microbiol Rev. 2015 Jul;28(3):541-63. doi: 10.1128/CMR.00075-13.
3
Lessons from Africa: developing a global human rights framework for tuberculosis control and prevention.非洲的经验教训:制定全球结核病防控人权框架。
BMC Int Health Hum Rights. 2014 Dec 3;14:34. doi: 10.1186/s12914-014-0034-7.
4
Global Health Governance at a Crossroads.全球卫生治理处于十字路口。
Glob Health Gov. 2011 Jun 21;3(2):1-37.

本文引用的文献

1
Rethinking equal access: agency, quality, and norms.重新思考平等获取:能动性、质量与规范。
Glob Public Health. 2007;2(1):78-96. doi: 10.1080/17441690600911480.
2
The clinical management of drug-resistant tuberculosis.耐多药结核病的临床管理
Curr Opin Pulm Med. 2007 May;13(3):212-7. doi: 10.1097/MCP.0b013e3280f3c0b2.
3
Extensively drug-resistant tuberculosis--United States, 1993-2006.广泛耐药结核病——美国,1993 - 2006年
MMWR Morb Mortal Wkly Rep. 2007 Mar 23;56(11):250-3.
4
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.广泛耐药结核病是南非农村地区结核病与艾滋病毒合并感染患者的死因之一。
Lancet. 2006 Nov 4;368(9547):1575-80. doi: 10.1016/S0140-6736(06)69573-1.
5
Ethics and governance of global health inequalities.全球健康不平等的伦理与治理
J Epidemiol Community Health. 2006 Nov;60(11):998-1003. doi: 10.1136/jech.2005.041947.
6
Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management.应对全球传染病爆发:非典在风险认知、沟通与管理方面的经验教训
Soc Sci Med. 2006 Dec;63(12):3113-23. doi: 10.1016/j.socscimed.2006.08.004. Epub 2006 Sep 15.
7
Tuberculosis drug development pipeline: progress and hope.结核病药物研发进展:现状与展望
Lancet. 2006 Mar 18;367(9514):945-7. doi: 10.1016/S0140-6736(06)68388-8.
8
Latent tuberculosis infection and BCG vaccination.潜伏性结核感染与卡介苗接种
J Midwifery Womens Health. 2005 Jul-Aug;50(4):344-7. doi: 10.1016/j.jmwh.2005.03.003.
9
Puppy love: bioterrorism, civil rights, and public health.初恋:生物恐怖主义、公民权利与公共卫生。
Fla Law Rev. 2003 Dec;55(5):1171-90.
10
When terrorism threatens health: how far are limitations on personal and economic liberties justified?当恐怖主义威胁健康时:对个人自由和经济自由的限制在多大程度上是合理的?
Fla Law Rev. 2003 Dec;55(5):1105-70.

广泛耐药结核病(XDR-TB)的控制:根本原因分析

Control of Extensively Drug-Resistant Tuberculosis (XDR-TB): A Root Cause Analysis.

作者信息

Ruger Jennifer Prah

机构信息

Associate Professor at Yale University Schools of Medicine, Public Health and Law (Adjunct) and Graduate School of Arts and Sciences.

出版信息

Glob Health Gov. 2010 Spring;3(2):1-20. Epub 2010 Apr 1.

PMID:22506090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3324909/
Abstract

The threat of global infectious agents has the potential to cripple national and global economies, as the outbreaks of SARS, Avian Flu, H1N1, and XDR-TB have demonstrated. This article offers a Root Cause Analysis (RCA) of one public health case study - the Speaker case of XDR-TB - pinpointing the underlying causal relationships associated with this global health incident and proposing recommendations for preventing its recurrence. An RCA approach identifies corrective actions directed at the root causes of the problem and advances them as necessary to eliminate global contagion with its major international public health risks. To my knowledge, this is the first root cause analysis of a global health problem. The reform this article proposes would be to add a standardized procedure akin to the informed consent process in clinical ethics, but within a shared health governance framework. This approach, addressing infectious agents at their origins or source, is potentially a more effective strategy to reduce uncertainty and avert global health threats.

摘要

正如非典、禽流感、甲型H1N1流感和广泛耐药结核病的爆发所表明的那样,全球传染病原体的威胁有可能使国家和全球经济陷入瘫痪。本文对一个公共卫生案例研究——广泛耐药结核病的议长案例进行了根本原因分析(RCA),找出了与这一全球卫生事件相关的潜在因果关系,并提出了预防其再次发生的建议。根本原因分析方法确定针对问题根源的纠正措施,并在必要时推进这些措施,以消除具有重大国际公共卫生风险的全球传染病。据我所知,这是对一个全球卫生问题的首次根本原因分析。本文提出的改革措施是在共享卫生治理框架内增加一个类似于临床伦理中知情同意程序的标准化程序。这种在传染病原体起源或源头解决问题的方法,可能是一种更有效的策略,以减少不确定性并避免全球卫生威胁。